Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis.
about
The Psychosis Recent Onset GRoningen Survey (PROGR-S): defining dimensions and improving outcomes in early psychosisResponding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis.Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.Socioeconomic status and prescribing for schizophrenia: analysis of 3200 cases from the Glasgow Psychosis Clinical Information System (PsyCIS)Medication nonadherence and psychiatry.Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013.Risk Factors for Obstructive Sleep Apnea Are Prevalent in People with Psychosis and Correlate with Impaired Social Functioning and Poor Physical Health.Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies.Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study.A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order.How should we manage anxiety in patients with schizophrenia?Scoping review of research in Australia on the co-occurrence of physical and serious mental illness and integrated care.Mental disorders and distress: Associations with demographics, remoteness and socioeconomic deprivation of area of residence across Australia.Prevalence and nature of antipsychotic polypharmacy among inpatients with schizophrenia spectrum disorders at an Australian mental health service.Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis.'That red flag on your file': misinterpreting physical symptoms as mental illness.Cardiometabolic comorbidities and life expectancy in people on medication for schizophrenia in Australia.We need to talk about depot: effect of Community Treatment Order on depot antipsychotic medication compliance.Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.Does evidence lead to policy change?
P2860
Q28545094-47B33021-0E16-4A03-B8D4-F9F9B37D8401Q30240167-36BDD997-85F0-46DC-8A9C-519D3B54ADF8Q31115350-02DA97DF-BBF7-4E31-B812-CD3BD2E48574Q33560808-F700A7A8-D0DC-46E5-B19D-9A3255BE3451Q33971229-8462F8AA-F9A7-4EEE-BE55-627D88E762E3Q34465134-6AD9DEA9-BB82-49B7-B32E-24EB039565CFQ34646095-82EDDCA6-9396-4291-B566-8500A21CB8E0Q37006387-6807E1CF-56D4-44ED-B31E-E1CD035BA645Q37218452-177F7D9B-8F5F-4832-96FF-751451AD6666Q37236148-D777F057-14FE-48F4-B145-1124A7400487Q37579469-F58BF818-2B6E-4844-8F90-F18B9743F13CQ38174188-D69E373E-7BDA-4F30-888B-29E90297306DQ38522507-84D45353-563F-46BE-A7AF-F6DB48592383Q38556463-AD5A267E-60A3-4A44-8EEF-10F2A700D9A4Q40330026-00D6DA77-1C16-4BD3-8896-80FBCA989C95Q43829173-DEC78D30-8BE4-4A7B-A4B1-EAAF4D2A2D6CQ47421031-DC6B2538-EA12-4561-89E4-FF3C557A516CQ48015847-E57F7E92-D579-4270-98E3-876B42501661Q49583891-8166A5DE-49CA-4171-AE4A-E54AD8BABDA7Q50638292-A0473D31-63A1-45C7-837A-A5BE35DA55C3Q50709810-DBC92ABD-F6F3-4779-A9E1-00013CE90D67Q50747717-CE7E8B5D-9381-4DF6-AD67-62491509E943
P2860
Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Medication for psychosis--cons ...... national survey of psychosis.
@en
Medication for psychosis--cons ...... national survey of psychosis.
@nl
type
label
Medication for psychosis--cons ...... national survey of psychosis.
@en
Medication for psychosis--cons ...... national survey of psychosis.
@nl
prefLabel
Medication for psychosis--cons ...... national survey of psychosis.
@en
Medication for psychosis--cons ...... national survey of psychosis.
@nl
P2093
P2860
P356
P1476
Medication for psychosis--cons ...... national survey of psychosis.
@en
P2093
Assen Jablensky
Cherrie Galletly
David Castle
Sonal Shah
Vera A Morgan
P2860
P304
P356
10.1177/0004867412450471
P577
2012-06-11T00:00:00Z